Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Kelch-like protein 15 (KLHL15) is a member of the kelch-like family of substrate adaptors for Cullin3-based E3 ubiquitin ligase complexes, characterized by an N-terminal BTB/POZ domain, a BACK domain, and C-terminal kelch repeats[1][3][4][5]. KLHL15 plays a role in protein homeostasis by targeting specific substrate proteins (such as the phosphatase PP2A subunit PPP2R5B and the DNA end-resection factor CtIP/RBBP8) for ubiquitination and proteasomal degradation, thereby regulating cytoskeletal organization, the DNA damage response, and neural development[1][3][4][7]. Disruption of KLHL15 function or mutations in KLHL15 have been linked to X-linked intellectual disability and developmental brain anomalies[1][3]. Emerging evidence also implicates KLHL15 in oncogenesis and as a putative cancer biomarker, particularly in the context of esophageal carcinoma[1]. KLHL15 is widely expressed in human tissues, reflecting its fundamental role in cellular homeostasis[2][8]. Notes: - This is not a traditional therapeutic target (e.g., receptor, druggable enzyme, transporter), so `is_target` is set to false since no drugs are reported to modulate KLHL15 directly per current knowledge or database results[3][4][6][7]. - `interacting_drugs` and `mechanism_of_action` are set to null, as there is no evidence of KLHL15 being directly targeted by pharmacological agents in public databases. - KLHL15 is best described as a substrate adaptor in ubiquitin ligase complexes and a pleiotropic regulator, with crucial roles in proteostasis, DNA repair, and neural development[1][3][4][7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Kelch-like protein 15 (KLHL15).